Investors

Corporate Profile

Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other targeted biological therapies. A Vaccinex antibody product is currently in clinical trials for immunotherapy of cancer and to prevent or delay the onset of neurodegenerative Huntington’s disease.
Upcoming Events
There are currently no events scheduled.

Copyright West LLC. Minimum 15 minutes delayed.